Conquering new heights in medical technology: Trivitron Healthcare

Established in the year 1997, Trivitron is the largest Indian MNC in medical technology. It is the only multi-modality medical technology company in India with presence in Cardiology and Implantable Devices (CID), Imaging Sciences, Lab Diagnostics (IVD), Critical Care & Life Support Solutions (CLSS) and ophthalmology. Headquartered in Chennai, Trivitron group’s products are now exported to over 165 countries including advanced markets like the US, Europe and Japan.

Today, Trivitron Healthcare, through its successful inorganic synergies with local and global firms, has a revenue turnover of Rs 750 crores .Starting off as a distribution firm, Trivitron has catapulted itself to being a leading manufacturer of medical equipment across the InVitro diagnostics, imaging, intensive care and operating room space. The eight in-house manufacturing facilities across Chennai, Mumbai, Pune and Helsinki are 100 per cent compliant with international standards set by bodies like FDA, CE, DCGI and PMDA.

In order to expand its manufacturing footprint, Trivitron has built the Trivitron Medical Technology Park in Sriperumbudur, spread across 25 acres of land and currently housing the Hitachi Aloka and Biosystems JV units, serving the value and premium societal segments. The growth of Trivitron has come through a string of alliances with international equipment manufactures such as Boston Scientific, Hitachi Medical System, Johnson Medical (Sweden) and Technolas Perfect Vision.

“To continue being India’s largest medical technology company even in future, Trivitron is in the transformation phase from being a pan India distribution company to enhancing the existing manufacturing capabilities with a view to sustain the business in the long run. The company aims to provide cost effective medical technology to people at large, says Veeraraghavan KL, Group CFO, Trivitron Healthcare.

With a belief that creativity fosters innovation and working towards this high performance mantra that embodies the organisational culture and its people, Trivitron has inked partnerships with LV Prasad Eye Institute, Anna University, IIT Madras and Sri Chitra Tirunal Institute of Medical Sciences and Technology across Ophthalmology, Imaging, Renal Care and Critical Care segments. The company has access to 16 patents in the IVD space and has recently filed a patent application towards a retinal screening device developed for diagnosing early stage diabetic retinopathy in un-dilated eyes.

Akshay Karoor, Marketing Manager, Trivitron says, “Enhancing access and affordability to advanced medical technology solutions through global collaborations and long-term customer relations are the key focus of Trivitron Healthcare.”

The current product portfolio that are manufactured and exported include the following: ultrasound equipment and colour dopplers, analog and digital X Ray Equipments, X Ray accessories and radiation protection apparels, ECG machines and patient monitors, Modular OT and pendants, infusion and syringe pumps, new born screening equipment and reagents, point of care and home care diagnostics reagents for women’s health, gastric disease, diagnostics instruments and reagents for biochemistry/haematology segments and immunoassay/molecular diagnostics products for infectious diseases/women’s health/gastric diseases and respiratory disorders. To attain growth and shore up operations globally and improve its market reach, the company has attracted private equity funding over the years, a few of who have had successful exits.

Trivitron group has a direct presence in India and is represented by its subsidiaries in the UAE, Sri Lanka, Finland and China. 55 per cent of the company’s revenue and 80 per cent of their profit comes from their own manufactured products thus telling the world that India’s medical technology story with local innovation and manufacturing is here to stay.

Trivitron plans to achieve their original target of Rs 1000 crores (for fiscal year 2012-2013) by the next financial year with over 65 per cent revenue and 90 per cent profit being contributed by their own manufacturing and innovation initiatives. The company has successfully transformed itself from being a trading company to a manufacturing, distributing and innovating company in its own rights.

The company is currently in the process of expanding its presence across the global markets through various marketing and support initiatives. Trivitron’s unique selling proposition is its 24X 7 strong customer support service that combines elements of logistics, engineering and clinical application, making it a service focused organisation. Trivitron is an equal employment opportunity employer. The group has more than 1000 employees on its rolls, backed with a strong management.

Contact Details:
Trivitron Healthcare
#15, IV Street
Abhiramapuram
Chennai – 600 018
Tel: (044) 2498 5050
Fax: (044) 2498 5757/ 2467 2782
Email: groupmaraketing@trivitron.com

For media queries contact: Eden Menon at 9869810067

Comments (0)
Add Comment